Published Date:2025-04-10 Original Link:https://www.onenessbio.com/en/news_detail352_2.htm No 3 Date of announcement 2025/04/10 Time of announcement 16:57:27 Subject Oneness has submitted 510(k) application of Bonvadis for full thickness wound indications to the U.S. FDA To which item it meets Subparagraph 10 Date of events  2025/04/10 Statement 1.    Date of occurrence of the event:2025/04/10 2.    New drug name or...Read More

Published Date:2025-04-10 Original Link:https://www.onenessbio.com/en/news_detail351_2.htm No 2 Date of announcement 2025/04/10 Time of announcement 16:45:21 Subject Announcement for the Board of Directors’ resolution to dispose of (sublease) part of a right-of-use assets to a related party. To which item it meets paragraph 20 Date of events  2025/04/10 Statement 1.Name and nature of the underlying asset (e.g.,...Read More

Published Date:2025-04-10 Original Link:https://www.onenessbio.com/en/news_detail350_2.htm No 1 Date of announcement 2025/04/10 Time of announcement 16:43:17 Subject Announcement for the Board of Directors’ resolution to acquire part of a right-of-use assets to a related party. To which item it meets paragraph 20 Date of events  2025/04/10 Statement 1.Name and nature of the underlying asset (e.g., land located...Read More